MacroGenics, Inc.
MGNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 159.4% | -61.9% | 98.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 91.7% | 85.6% | 95.1% | 96.5% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -38.7% | 3.5% | -71.9% | -252.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -45.1% | -15.8% | -79.8% | -267.2% |
| EPS Diluted | -1.07 | -0.15 | -1.95 | -3.18 |
| % Growth | -613.3% | 92.3% | 38.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |